Africa Finance Today
SEE OTHER BRANDS

The best finance and banking news from Africa

Africa Finance Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa Finance Today.

Press releases published on May 8, 2025

Stack Capital Group Inc. Reports Q1-2025 Financial Results

Stack Capital Group Inc. Reports Q1-2025 Financial Results

TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Stack Capital Group Inc., (“Stack Capital” or the “Company”) (TSX:STCK; TSX:STCK.WT.A) today announced its financial results for the quarter ended March 31, 2025. Stack Capital reports all amounts in Canadian …

MarketWise Reports Net Revenue of $83.5 Million for First Quarter 2025 and Net Income of $16.8 Million; First Quarter Billings Increase 27% from Prior Quarter; Cash From Operating Activities Improves by $20.2 Million; Provides FY 2025 Financial…

MarketWise Reports Net Revenue of $83.5 Million for First Quarter 2025 and Net Income of $16.8 Million; First Quarter Billings Increase 27% from Prior Quarter; Cash From Operating Activities Improves by $20.2 Million; Provides FY 2025 Financial…

BALTIMORE, May 08, 2025 (GLOBE NEWSWIRE) -- MarketWise, Inc. (NASDAQ: MKTW) (“MarketWise” or the “Company”), a leading multi-brand digital subscription services platform that provides premium financial research, software, education, and tools for self- …

OrganOx Announces Second Private Placement Closing, Investments by Intuitive Ventures and Terumo Ventures

OrganOx Announces Second Private Placement Closing, Investments by Intuitive Ventures and Terumo Ventures

OXFORD, England and MADISON, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., a leading organ medical technology company, completed a second closing of its private placement with investments from Intuitive Ventures, Terumo Ventures, and Piper Heartland …

Pasinex Announces Issuance of Failure to File Cease Trade Order

Pasinex Announces Issuance of Failure to File Cease Trade Order

TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Pasinex Resources Limited (CSE: PSE) (FSE: PNX) ("Pasinex" or the "Company") today announced that the British Columbia Securities Commission, as its principal regulator, has issued a Failure to File Cease Trade …

TEGNA Inc. Reports First Quarter 2025 Results and Provides Second Quarter Guidance

TEGNA Inc. Reports First Quarter 2025 Results and Provides Second Quarter Guidance

Achieves first quarter key guidance metrics Reaffirms 2024/2025 two-year Adjusted Free Cash Flow guidance TYSONS, Va., May 08, 2025 (GLOBE NEWSWIRE) -- TEGNA Inc. (NYSE: TGNA) today announced financial results for the first quarter ended March 31, 2025. “ …

CoreCard Corporation Reports First Quarter 2025 Results

CoreCard Corporation Reports First Quarter 2025 Results

NORCROSS, Ga., May 08, 2025 (GLOBE NEWSWIRE) -- CoreCard Corporation (NYSE: CCRD) (“CoreCard” or the “Company”), the leading provider of innovative credit technology solutions and processing services to the financial technology and services market, …

Savaria announces the acquisition of Western Elevator Ltd.

Savaria announces the acquisition of Western Elevator Ltd.

LAVAL, Québec, May 08, 2025 (GLOBE NEWSWIRE) -- Savaria Corporation (“Savaria”) (TSX:SIS), a global leader in the accessibility industry, is pleased to announce the acquisition of Western Elevator Ltd. (“Western”), a premier home elevator and lift dealer …

Savaria annonce l’acquisition de Western Elevator Ltd.

Savaria annonce l’acquisition de Western Elevator Ltd.

LAVAL, Québec, 08 mai 2025 (GLOBE NEWSWIRE) -- Corporation Savaria (« Savaria ») (TSX : SIS) un chef de file mondial de l’industrie de l’accessibilité, a le plaisir d'annoncer l'acquisition de Western Elevator Ltd. (« Western »), un revendeur d'ascenseurs …

Altimmune Presents New Analyses Predicting High Rates of MASH Resolution on Biopsy following Pemvidutide Treatment at the EASL International Liver Congress™

Altimmune Presents New Analyses Predicting High Rates of MASH Resolution on Biopsy following Pemvidutide Treatment at the EASL International Liver Congress™

GAITHERSBURG, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing next-generation peptide-based therapeutics for liver and cardiometabolic diseases, today announced the …

Intellia Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Company Progress

Intellia Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Company Progress

On track to complete enrollment of the global Phase 3 HAELO study in hereditary angioedema (HAE) in the third quarter of 2025 Dosed first patient in the global Phase 3 MAGNITUDE-2 study evaluating nexiguran ziclumeran (nex-z) in patients with hereditary …

Knight Therapeutics Reports First Quarter 2025 Results

Knight Therapeutics Reports First Quarter 2025 Results

MONTREAL, May 08, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its first quarter ended March 31, 2025. All currency …

Thérapeutique Knight déclare ses résultats du premier trimestre de 2025

Thérapeutique Knight déclare ses résultats du premier trimestre de 2025

MONTRÉAL, 08 mai 2025 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight » ou la « Société »), une société pharmaceutique spécialisée panaméricaine (à l’exclusion des É.-U.), a annoncé aujourd’hui ses résultats financiers pour le premier …

MACOM Reports Fiscal Second Quarter 2025 Financial Results

MACOM Reports Fiscal Second Quarter 2025 Financial Results

LOWELL, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- MACOM Technology Solutions Holdings, Inc. (“MACOM”) (Nasdaq: MTSI), a leading supplier of semiconductor products, today announced its financial results for its fiscal second quarter ended April 4, 2025. …

Cronos Group Reports 2025 First Quarter Results

Cronos Group Reports 2025 First Quarter Results

Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis PEACE NATURALS® retained its position as the number one cannabis brand in Israel1 Industry-leading balance sheet with $838 million in …

Dyne Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights

Dyne Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights

- FDA (CDER) Type C meeting held in May 2025 for DYNE-101 in DM1 and Dyne plans to provide a regulatory update following receipt of meeting minutes - - Registrational Expansion Cohort of ACHIEVE Trial of DYNE-101 in DM1 initiated to support potential …

Kelly Reports First-Quarter 2025 Earnings

Kelly Reports First-Quarter 2025 Earnings

TROY, Mich., May 08, 2025 (GLOBE NEWSWIRE) -- Kelly (Nasdaq: KELYA, KELYB), a leading specialty talent solutions provider, today announced results for the first quarter of 2025.   Q1 revenue of $1.16 billion, up 11.5% year-over-year reflecting previously …

Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2025 Financial Results

Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2025 Financial Results

Updated Phase 2 data to be presented at ASCO for vilastobart, a tumor-activated, Fc-enhanced, anti-CTLA-4, in combination with atezolizumab in patients with metastatic microsatellite stable colorectal cancer (MSS CRC) Advancing multiple masked T cell …

Warner Music Group Corp. Reports Results for Fiscal Second Quarter Ended March 31, 2025

Warner Music Group Corp. Reports Results for Fiscal Second Quarter Ended March 31, 2025

Financial Highlights Q2 Performance Driven by Revenue Growth Across Recorded Music and Music Publishing Cost Savings Plans on Track, With Reinvestment Initiatives Accelerating Year-to-Date Operating Cash Flow and Free Cash Flow Increased by 53% and 59%, …

Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update

Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update

Dosing complete in the first two cohorts of INLIGHT trial in obesity of WVE-007 (INHBE siRNA), designed to induce healthy weight loss by reducing fat without impacting muscle; clinical data on track for 2H 2025 Dosing underway in second single dose cohort …

Caliber Announces First Quarter 2025 Earnings Release & Conference Call

Caliber Announces First Quarter 2025 Earnings Release & Conference Call

SCOTTSDALE, Ariz., May 08, 2025 (GLOBE NEWSWIRE) -- Caliber (NASDAQ: CWD), a real estate investor, developer, and manager, today announced that it will release its first quarter 2025 financial results after the close of the market on Thursday, May 15, 2025 …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service